The UVACCC Accelerating Innovation Fund was created by the Cancer Center to support innovative cancer-relevant biomedical research projects at the University of Virginia. The goal of this program is to support cancer research projects that turn scientific insights into tangible advancements that can positively impact the lives of patients, such as developing new therapies, improving diagnostics, and screening technologies, creating digital interventions, and enhancing patient care practices. This is a multidisciplinary effort that requires collaboration among researchers, clinicians, and/or professionals who work with the targeted population. The program’s desired outcomes focus on advancing healthcare through research and innovation to ultimately improve patient outcomes, increase the precision of diagnosis and treatment, and enhance the overall healthcare experience. Funded projects will not only generate valuable knowledge to improve patient lives but also have real-world impact by creating intellectual property, forming partnerships with industry, or launching new companies to bring innovations to market.
Award: Up to $150,000 (direct costs only) for 1 year.
Eligibility:
- Applicants must be UVACC members or have applied to become a member.
- Each proposal must have at least two co-investigators, one of whom must be a professional who directly interacts with the targeted population.
- Eligible investigators may submit more than one proposal.
- Awardees from previous funding cycles are eligible to apply, and competitive renewal applications should include a description of milestone achieved vs. those planned in the original submission and any challenges during the funding period.
Deadline: Closed (RFA to be released each January).
Contact for Questions: Please contact Sharon Krueger, Program Director at sak8e@virginia.edu.